Clinical trial
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety, Tolerability, and Single-Dose Pharmacokinetics of MK0462 in Subjects With Migraines Aged 6 to 17 Years
NCT00604812 is registered in ClinicalTrials.gov with Organon and Co as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety, Tolerability, and Single-Dose Pharmacokinetics of MK0462 in Subjects With Migraines Aged 6 to 17 Years
- Lead sponsor
- Organon and Co
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- December 17, 2007
- Completion date
- September 17, 2010
- Enrollment
- 31 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.